Introduction and Objective: High HbA1c is linked to lower aerobic exercise capacity (VO2peak), even when exercise-training levels are matched, suggesting hyperglycemia may alter the adaptive response to exercise. Each acute bout of exercise induces changes in circulating proteins that mediate exercise response. We determined how T1D alters circulating proteins at rest and with exercise and […]
Read MoreCategory: Diabetes
1016-OR: Continuous Glucose Monitoring (CGM) Coverage Policy, Access, and Utilization in Nonprofit Community Health Plans
Introduction and Objective: The Alliance of Community Health Plans (ACHP) is a nonprofit trade association representing nonprofit community health plans. To advance its Chronic Disease Pledge to improve diabetes outcomes by 2030, ACHP members worked together with the International Diabetes Center to understand payer policies related to continuous glucose monitoring (CGM). This project, supported by […]
Read More2524-P: Acute Glycemic Variability and Outcome in Sepsis: A Prospective Study
Introduction and Objective: Emerging evidence suggests that glycemic variability may influence outcomes in sepsis. Our objective was to investigate the correlation between acute glycemic variability and mortality as well as other clinical outcomes in sepsis.Methods: Patients aged 18 years or older with sepsis were enrolled in this prospective observational study during 2024-2025. Capillary blood glucose […]
Read More1656-P: TEPLI-REAL: A Real-World Retrospective Study Characterizing Screening and Treatment Patterns for Type 1 Diabetes (T1D) in Individuals Treated with Teplizumab in the U.S.
Introduction and Objective: Teplizumab (TPZ), an anti-CD3 monoclonal antibody, is approved in the US to delay stage 3 T1D onset in individuals aged ≥8 years (y) with stage 2 T1D. We present screening and real-world treatment (Tx) patterns from individuals in the US who received TPZ according to their age group.Methods: TEPLI-REAL (NCT06892002) was a […]
Read More2523-P: Early Glycemic Deterioration and Baseline Risk Prediction of Insulin-Like Growth Factor-1 Receptor Inhibitor Therapy
Introduction and Objective: Insulin-like growth factor-1 receptor (IGF-1R) inhibitor has been developed as an effective therapy for thyroid eye disease (TED). However, treatment-associated hyperglycemia remains a clinical concern. We aimed to examine whether early glycemic deterioration during IGF-1R inhibitor therapy is associated with subsequent glycemic trajectories and to develop and validate a risk prediction model.Methods: […]
Read More1561-P: Physical Activity Goal Attainment among Women Veterans Participants in Virtual Diabetes Prevention Program (DPP): The Role of Session Completion, Self-Monitoring, and Social Interactions
Introduction and Objective: The Diabetes Prevention Program’s (DPP) standardized goal of ≥150 mins of physical activity (PA)/week leads to long-term health benefits. We examined the association between virtual DPP PA goal attainment and three distinct program engagement components: session completion, self-monitoring, and social interactions.Methods: We included women Veterans participating in virtual DPP across 11 VA […]
Read More3110-LB: RNF20, an Epigenetic Modifier, Is Essential for Pancreatic Organogenesis and Neonatal Islet Function
Introduction and Objective: Pancreatic islets maintain glucose homeostasis, with diabetes mellitus arising from autoimmune destruction (T1D) or dysregulation (T2D) of insulin-producing pancreatic β-cells. While exogenous insulin treats T1D, transplanted stem cell-derived islet-like cells may offer improved glycemic control with fewer long-term complications. However, a better understanding of pancreas and islet development is needed for successfully […]
Read More1425-P: Modelling Vascular Dysfunction in Lean Type 2 Diabetes Using IPSC-Derived Endothelial Cells Under Metabolic Stress
Introduction and Objective: Although obesity is a major driver of type 2 diabetes (T2D), lean T2D represents 3-8% of global cases and remains understudied. Diabetes-associated cardiovascular disease is well characterized; vascular modeling of lean T2D is limited. We aim to determine whether induced pluripotent stem cell (iPSC)-derived endothelial cells from patients with lean T2D exhibit […]
Read More1067-OR: A Multicenter Trial Assessing the Efficacy and Safety of the Novel Twiist Automated Insulin Delivery (AID) System in Adults with Insulin-Treated Type 2 Diabetes (T2D)
Introduction and Objective: Despite GLP1ra or SGLT2i therapy, many adults with insulin treated type 2 diabetes (T2D) remain above HbA1c targets. AID may provide benefit for T2D. The study objective was to evaluate efficacy and safety of the twiist AID system, which uses the novel twiist pump and Tidepool Loop algorithm, in adults with insulin-treated […]
Read More2800-LB: Virtual Diabetes Self-Management Environment on Perceived Social Support and Clinical Outcomes in Adults with Type 2 Diabetes: A 12-Month Secondary Analysis of a Randomized Controlled Trial
Introduction and Objective: Virtual environments may enhance social support through interactive and immersive engagement; however, evidence of their long-term impact remains limited. This study aims to examine the effect of a 3D virtual diabetes self-management education and support (DSME/S) intervention (Learning in a Virtual Environment [LIVE]) on perceived social support and its association with behavioral […]
Read More